2016 VAM: 2306 - Managing Stinging Insect Allergy in the 21st Century
This session discusses the state of the art in the diagnosis and management of the stinging insect allergy.
AMA PRA Category 1 Credits™: 1.25
Credit must be claimed by May 31, 2018. Any credit request on or after June 1, 2018 will be subject to an administrative fee.
Allied Health Professionals
Upon completion of this activity, participants will be able to:
1. Describe the mechanism of tolerance development during venom immunotherapy
2. Assess the indications for initiation and discontinuation of venom immunotherapy
3. Evaluate the overlap between venom-induced anaphylaxis and mast cell disorders
Prof. Cezmi A. Akdis, MD FAAAAI, Swiss Institute of Allergy and Asthma Research, Davos, Switzerland
Dr. Mariana C. Castells, MD PhD FAAAAI, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
Dr. David B.K. Golden, MD FAAAAI, Johns Hopkins University, Baltimore, MD
- 1.25 AttendanceAttendance credit.
- 1.25 CECE credit.
- 1.25 CMECME credit.